Mid-Afternoon Market Update: Dow Tumbles 2.5%; BeyondSpring Shares Plunge

Toward the end of trading Monday, the Dow traded down 2.57% to 33,696.98 while the NASDAQ fell 3.14% to 14,572.25. The S&P also fell, dropping 2.58% to 4,318.67.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 42,088,400 cases with around 673,760 deaths. India confirmed a total of at least 33,478,410 cases and 445,130 deaths, while Brazil reported over 21,239,780 COVID-19 cases with 590,750 deaths. In total, there were at least 228,595,280 cases of COVID-19 worldwide with more than 4,692,920 deaths, according to data compiled by Johns Hopkins University.


Leading and Lagging Sectors


Utilities shares fell 0.6% on Monday. Meanwhile, top gainers in the sector included Companhia Paranaense de Energia - COPEL ELP, up 3% and Enel Chile S.A. ENIC up 3%.


In trading on Monday, energy shares tumbled 3.4%.


Top Headline

Private equity firm Thomas H. Lee Partners, L.P. has agreed to acquire Brooks Automation Inc's BRKS Semiconductor Solutions Group business in a transaction valued at $3 billion. The transaction is likely to close in the first half of CY22


Equities Trading UP


ZIVO Bioscience, Inc. ZIVO shares shot up 82% to $5.10.


Shares of Edesa Biotech, Inc. EDSA got a boost, shooting 79% to $10.54 after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized COVID-19 patients.


Synlogic, Inc. SYBX shares were also up, gaining 12% to $3.70 after the company announced Phase 2 data demonstrating reduction in plasma phenylalanine levels in patients with phenylketonuria.

Check out these big movers of the day


Equities Trading DOWN

BeyondSpring Inc. BYSI shares tumbled 32% to $15.51 after the company shared the final intention-to-treat (ITT) dataset from its DUBLIN-3 Phase 3 trial of plinabulin. The trial evaluated plinabulin combined with docetaxel vs. docetaxel alone for 2nd/3rd line non-small cell lung cancer (NSCLC) patients with EGFR wild type.

Shares of Helbiz, Inc. HLBZ were down 18% to $14.42. Helbiz shares jumped around 97% on Friday after the company announced its media unit has entered into an agreement with FOX Networks to broadcast the Italian Serie B championship across the USA and the Caribbean.

Protagonist Therapeutics, Inc. PTGX was down, falling 24% to $13.27. JP Morgan downgraded Protagonist Therapeutics from Overweight to Neutral and announced a $49 price target. The FDA recently placed a clinical hold on the company’s rusfertide development program.


Commodities


In commodity news, oil traded down 2.5% to $70.18, while gold traded up 0.6% to $1,761.90.


Silver traded down 0.8% Monday to $22.165 while copper fell 3.3% to $4.1070.


Euro zone

European shares closed lower today. The eurozone’s STOXX 600 fell 1.67%, the Spanish Ibex Index fell 1.2% and the German DAX 30 dropped 2.31%. Meanwhile, the London’s FTSE 100 fell 0.86%, French CAC 40 declined 1.74% and Italy’s FTSE MIB tumbled 2.57%.

German producer prices increased 12.0% year-over-year in August following a 10.4% growth in the prior month. Spanish trade deficit widened to EUR 1.60 billion in July, compared to EUR 0.31 billion in the year-ago month.


Economics

The NAHB housing market index rose to 76 in September from 75 in August.


Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Afternoon Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...